Drug Profile
Nefopam topical cream - ScarX Therapeutics
Alternative Names: SCX-001Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator ScarX Therapeutics
- Class Antifibrotics; Non-opioid analgesics; Small molecules
- Mechanism of Action Beta catenin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertrophic scars
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for phase-I development in Hypertrophic-scars(In volunteers) in Canada (Topical, Cream)
- 27 Jun 2017 ScarX Therapeutics completes enrolment in its phase I trial for Hypertrophic scars in Canada (NCT03036306)
- 18 Aug 2016 Health Canada approves IND application for nefopam cream in Hypertrophic scars